Supplement reference
Beta-Glucan
A sourced reference on Beta-Glucan identity, evidence limits and safety context.
Source and review status
Published sources checked
Sources checked on: 6 September 2026
Qualified clinical review: Pending. This page has not been clinically reviewed.
About this source check
AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.
Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 March 2027.
What it is
Beta-glucan is a class of polysaccharides from sources including oats, barley, yeast and fungi. Source and molecular structure matter.
Sources: National Library of Medicine, PubMed
What the cited evidence shows
A systematic review of 30 randomised trials of commercial beta-glucan products found mostly small studies and surrogate outcomes. It characterised conclusions as preliminary because study quality and outcome relevance were limited.
Sources: National Library of Medicine, PubMed
Limits and safety context
This review does not establish an immune-treatment or infection-prevention claim for a generic beta-glucan product.
Sources: National Library of Medicine, PubMed
Published sources
- Commercial beta-glucan products: systematic review of randomised trials
National Library of Medicine, PubMed. 2019; accessed 6 September 2026.
Supports: Thirty trials, mostly small and using surrogate outcomes; authors describe conclusions as preliminary.
Change history
| Date | Change | Clinical-review status |
|---|---|---|
| 6 September 2026 | Source-linked reference published | Pending |
Keep a private record
UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.